Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Proc Natl Acad Sci U S A ; 119(3)2022 01 18.
Article in English | MEDLINE | ID: mdl-35017298

ABSTRACT

Neurons derived from human induced pluripotent stem cells (hiPSCs) have been used to model basic cellular aspects of neuropsychiatric disorders, but the relationship between the emergent phenotypes and the clinical characteristics of donor individuals has been unclear. We analyzed RNA expression and indices of cellular function in hiPSC-derived neural progenitors and cortical neurons generated from 13 individuals with high polygenic risk scores (PRSs) for schizophrenia (SCZ) and a clinical diagnosis of SCZ, along with 15 neurotypical individuals with low PRS. We identified electrophysiological measures in the patient-derived neurons that implicated altered Na+ channel function, action potential interspike interval, and gamma-aminobutyric acid-ergic neurotransmission. Importantly, electrophysiological measures predicted cardinal clinical and cognitive features found in these SCZ patients. The identification of basic neuronal physiological properties related to core clinical characteristics of illness is a potentially critical step in generating leads for novel therapeutics.


Subject(s)
Cognition/physiology , Electrophysiological Phenomena , Induced Pluripotent Stem Cells/physiology , Neurons/physiology , Schizophrenia/physiopathology , Animals , Cell Line , Cellular Reprogramming , Cerebral Cortex/pathology , Humans , Ion Channel Gating , Kinetics , Male , Phenotype , Rats , Schizophrenia/diagnosis , Sodium Channels/metabolism
2.
Nat Commun ; 11(1): 462, 2020 01 23.
Article in English | MEDLINE | ID: mdl-31974374

ABSTRACT

Human induced pluripotent stem cells (hiPSCs) are a powerful model of neural differentiation and maturation. We present a hiPSC transcriptomics resource on corticogenesis from 5 iPSC donor and 13 subclonal lines across 9 time points over 5 broad conditions: self-renewal, early neuronal differentiation, neural precursor cells (NPCs), assembled rosettes, and differentiated neuronal cells. We identify widespread changes in the expression of both individual features and global patterns of transcription. We next demonstrate that co-culturing human NPCs with rodent astrocytes results in mutually synergistic maturation, and that cell type-specific expression data can be extracted using only sequencing read alignments without cell sorting. We lastly adapt a previously generated RNA deconvolution approach to single-cell expression data to estimate the relative neuronal maturity of iPSC-derived neuronal cultures and human brain tissue. Using many public datasets, we demonstrate neuronal cultures are maturationally heterogeneous but contain subsets of neurons more mature than previously observed.


Subject(s)
Cell Differentiation/genetics , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/physiology , Neural Stem Cells/physiology , Transcriptome , Algorithms , Animals , Astrocytes/cytology , Cells, Cultured , Cerebral Cortex/cytology , Coculture Techniques , Databases, Genetic , Gene Expression Regulation , Humans , Models, Neurological , Neural Stem Cells/cytology , Neurons/cytology , Neurons/physiology , Rats
3.
Cell Rep ; 22(10): 2601-2614, 2018 03 06.
Article in English | MEDLINE | ID: mdl-29514090

ABSTRACT

Diverse cell types can be reprogrammed into pluripotent stem cells by ectopic expression of Oct4 (Pou5f1), Klf4, Sox3, and Myc. Many of these induced pluripotent stem cells (iPSCs) retain memory, in terms of DNA methylation and histone modifications (epigenetic memory), of their cellular origins, and this may bias subsequent differentiation. Neurons are difficult to reprogram, and there has not been a systematic side-by-side characterization of reprogramming efficiency or epigenetic memory across different neuronal subtypes. Here, we compare reprogramming efficiency of five different retinal cell types at two different stages of development. Retinal differentiation from each iPSC line was measured using a quantitative standardized scoring system called STEM-RET and compared to the epigenetic memory. Neurons with the lowest reprogramming efficiency produced iPSC lines with the best retinal differentiation and were more likely to retain epigenetic memory of their cellular origins. In addition, we identified biomarkers of iPSCs that are predictive of retinal differentiation.


Subject(s)
Cellular Reprogramming , DNA Methylation , Histones/metabolism , Organogenesis , Organoids/growth & development , Protein Processing, Post-Translational , Retina/cytology , Retina/metabolism , Animals , Biomarkers/metabolism , Cell Culture Techniques , Cell Differentiation , Cell Nucleus/metabolism , Enhancer Elements, Genetic/genetics , Epigenesis, Genetic , Induced Pluripotent Stem Cells/metabolism , Kruppel-Like Factor 4 , Mice , Promoter Regions, Genetic/genetics
4.
Neuron ; 94(3): 550-568.e10, 2017 May 03.
Article in English | MEDLINE | ID: mdl-28472656

ABSTRACT

In the developing retina, multipotent neural progenitors undergo unidirectional differentiation in a precise spatiotemporal order. Here we profile the epigenetic and transcriptional changes that occur during retinogenesis in mice and humans. Although some progenitor genes and cell cycle genes were epigenetically silenced during retinogenesis, the most dramatic change was derepression of cell-type-specific differentiation programs. We identified developmental-stage-specific super-enhancers and showed that most epigenetic changes are conserved in humans and mice. To determine how the epigenome changes during tumorigenesis and reprogramming, we performed integrated epigenetic analysis of murine and human retinoblastomas and induced pluripotent stem cells (iPSCs) derived from murine rod photoreceptors. The retinoblastoma epigenome mapped to the developmental stage when retinal progenitors switch from neurogenic to terminal patterns of cell division. The epigenome of retinoblastomas was more similar to that of the normal retina than that of retina-derived iPSCs, and we identified retina-specific epigenetic memory.


Subject(s)
Carcinogenesis/genetics , Cell Differentiation/genetics , Cellular Reprogramming/genetics , DNA Methylation/genetics , Epigenesis, Genetic , Histone Code/genetics , Retina/metabolism , Retinoblastoma/genetics , Animals , Animals, Genetically Modified , Disease Models, Animal , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Mice , Mouse Embryonic Stem Cells/cytology , Mouse Embryonic Stem Cells/metabolism , Retina/embryology , Retinal Rod Photoreceptor Cells/cytology , Retinoblastoma Protein/genetics
5.
Nat Protoc ; 11(10): 1955-1976, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27658012

ABSTRACT

Postmitotic differentiated neurons are among the most difficult cells to reprogram into induced pluripotent stem cells (iPSCs) because they have poor viability when cultured as dissociated cells. To overcome this, other protocols have required the inactivation of the p53 tumor suppressor to reprogram postmitotic neurons, which can result in tumorigenesis of the cells. We describe a method that does not require p53 inactivation but induces reprogramming in retinal cells from reprogrammable mice grown in aggregates with wild-type mouse retinal cells. After the first 10 d of reprogramming, the aggregates are then dispersed and plated on irradiated feeder cells to propagate and isolate individual iPSC clones. The reprogramming efficiency of different neuronal populations at any stage of development can be quantified using this protocol. Reprogramming retinal neurons using this protocol will take 56 d, and these retina-derived iPSCs can undergo retinal differentiation to produce retinae in 34 d. In addition, we describe a quantitative assessment of retinal differentiation from these neuron-derived iPSCs called STEM-RET. The procedure quantifies eye field specification, optic cup formation and retinal differentiation in 3D cultures using molecular, cellular and morphological criteria. An advanced level of cell culture experience is required to carry out this protocol.

6.
Cell Stem Cell ; 17(1): 101-15, 2015 Jul 02.
Article in English | MEDLINE | ID: mdl-26140606

ABSTRACT

Cell-based therapies to treat retinal degeneration are now being tested in clinical trials. However, it is not known whether the source of stem cells is important for the production of differentiated cells suitable for transplantation. To test this, we generated induced pluripotent stem cells (iPSCs) from murine rod photoreceptors (r-iPSCs) and scored their ability to make retinae by using a standardized quantitative protocol called STEM-RET. We discovered that r-iPSCs more efficiently produced differentiated retinae than did embryonic stem cells (ESCs) or fibroblast-derived iPSCs (f-iPSCs). Retinae derived from f-iPSCs had fewer amacrine cells and other inner nuclear layer cells. Integrated epigenetic analysis showed that DNA methylation contributes to the defects in f-iPSC retinogenesis and that rod-specific CTCF insulator protein-binding sites may promote r-iPSC retinogenesis. Together, our data suggest that the source of stem cells is important for producing retinal neurons in three-dimensional (3D) organ cultures.


Subject(s)
Epigenesis, Genetic , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Retina/growth & development , Retinal Rod Photoreceptor Cells/cytology , Retinal Rod Photoreceptor Cells/metabolism , Animals , Cell Culture Techniques/methods , Cell Differentiation , Cell Line , Cellular Reprogramming , DNA Methylation , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Humans , Mice , Mice, Transgenic , Retina/cytology , Retina/metabolism , Retinal Degeneration/genetics , Retinal Degeneration/pathology , Retinal Degeneration/therapy
7.
Proc Natl Acad Sci U S A ; 108(52): 21111-6, 2011 Dec 27.
Article in English | MEDLINE | ID: mdl-22160703

ABSTRACT

Neuronal differentiation with respect to the acquisition of synaptic competence needs to be regulated precisely during neurogenesis to ensure proper formation of circuits at the right place and time in development. This regulation is particularly important for synaptic triads among photoreceptors, horizontal cells (HCs), and bipolar cells in the retina, because HCs are among the first cell types produced during development, and bipolar cells are among the last. HCs undergo a dramatic transition from vertically oriented neurites that form columnar arbors to overlapping laminar dendritic arbors with differentiation. However, how this process is regulated and coordinated with differentiation of photoreceptors and bipolar cells remains unknown. Previous studies have suggested that the retinoblastoma (Rb) tumor suppressor gene may play a role in horizontal cell differentiation and synaptogenesis. By combining genetic mosaic analysis of individual synaptic triads with neuroanatomic analyses and multiphoton live imaging of developing HCs, we found that Rb plays a cell-autonomous role in the reorganization of horizontal cell neurites as they differentiate. Aberrant vertical processes in Rb-deficient HCs form ectopic synapses with rods in the outer nuclear layer but lack bipolar dendrites. Although previous reports indicate that photoreceptor abnormalities can trigger formation of ectopic synapses, our studies now demonstrate that defects in a postsynaptic partner contribute to the formation of ectopic photoreceptor synapses in the mammalian retina.


Subject(s)
Cell Differentiation/physiology , Dendrites/physiology , Neurogenesis/physiology , Retinal Horizontal Cells/cytology , Retinoblastoma Protein/metabolism , Synapses/physiology , Animals , Mice , Microscopy, Confocal , Microscopy, Electron, Transmission , Retinoblastoma Protein/genetics
8.
Int J Cancer ; 126(3): 620-30, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19637242

ABSTRACT

The tumor stroma has significant effects on cancer cell growth and metastasis. Interactions between cancer and stromal cells shape tumor progression through poorly understood mechanisms. One factor regulating tumor growth is the circadian timing system that generates daily physiological rhythms throughout the body. Clock genes such as mPer1 serve in molecular timing events of circadian oscillators and when mutated can disrupt circadian rhythms and accelerate tumor growth. Stimulation of mPer1 by cytokines suggests that the timing of circadian oscillators may be altered by these tumor-derived signals. To explore tumor and stromal interactions, the pattern of mPer1 expression was imaged in tumors generated through subcutaneous injection of Lewis lung carcinoma (LLC) cells. Several imaging studies have used bioluminescent cancer cell lines expressing firefly luciferase to image tumor growth in live mice. In contrast, this study used non-bioluminescent cancer cells to produce tumors within transgenic mice expressing luciferase controlled by the mPer1 gene promoter. Bioluminescence originated only in host cells and was significantly elevated throughout the tumor stroma. It was detected through the skin of live mice or by imaging the tumor directly. No effects on the circadian timing system were detected during three weeks of tumor growth according to wheel-running rhythms. Similarly, no effects on mPer1 expression outside the tumor were found. These results suggest that mPer1 activity may play a localized role in the interactions between cancer and stromal cells. The effects might be exploited clinically by targeting the circadian clock genes of stromal cells.


Subject(s)
Carcinoma, Lewis Lung/metabolism , Luciferases, Firefly/analysis , Period Circadian Proteins/physiology , Animals , Carcinoma, Lewis Lung/pathology , Circadian Rhythm/genetics , Female , Genes, Reporter , Genes, Synthetic , Luciferases, Firefly/genetics , Luminescent Measurements , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Activity/genetics , Neoplasm Transplantation , Organ Specificity , Period Circadian Proteins/biosynthesis , Period Circadian Proteins/genetics , Promoter Regions, Genetic , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Stromal Cells/metabolism , Stromal Cells/pathology , Subcutaneous Tissue
9.
Brain Res ; 1214: 84-93, 2008 Jun 12.
Article in English | MEDLINE | ID: mdl-18472091

ABSTRACT

The circadian timing system includes the major circadian pacemaker in the suprachiasmatic nucleus (SCN) of the hypothalamus and less well characterized circadian pacemakers in the brain and peripheral tissues throughout the body. The coupling between these discrete circadian clocks is not well understood, although individual neurons of the SCN are considered competent circadian pacemakers that interact to produce rhythms in the SCN and in its afferents. Because the SCN is a complex assemblage of small neurons of several phenotypes, we sought a simpler circadian brain nucleus with larger neurons that might provide insight into circadian timing not easily obtained from the SCN. Using bioluminescence imaging of brain tissue explants from transgenic mice containing the firefly luciferase gene luc controlled by the mPer1 promoter, we discovered elevated transgene expression throughout the mesencephalic trigeminal nucleus (Me5) of the brain stem. Large sensory neurons of the Me5 receive proprioceptive signals from periodontal ligaments and masseter muscle spindles. The Me5 cells displayed circadian rhythms with elevated expression in culture corresponding with the dark portion of the prior light cycle. Because of known interactions between the Me5 and the tuberomammillary nucleus and because of the role of both nuclei in satiety, it is possible that a circadian clock in the Me5 serves in regulating daily feeding behavior. This newly identified circadian pacemaker in the Me5 may prove useful for single-cell analyses of circadian gene expression in clock cells and for comparison with the SCN.


Subject(s)
Cell Cycle Proteins/metabolism , Circadian Rhythm/physiology , Gene Expression/physiology , Neurons/metabolism , Nuclear Proteins/metabolism , Trigeminal Nuclei/metabolism , Animals , Cell Cycle Proteins/genetics , Mice , Mice, Transgenic , Nuclear Proteins/genetics , Organ Culture Techniques , Period Circadian Proteins , Suprachiasmatic Nucleus/metabolism , Trigeminal Nuclei/cytology
10.
Photochem Photobiol Sci ; 5(11): 1082-5, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17077906

ABSTRACT

Mice expressing the firefly luciferase gene luc under the control of various gene promoters are used to image long-term changes in tumor growth, infection, development, and circadian rhythms. This novel approach enables ongoing regulation of gene expression to be visualized through repeated imaging of luciferase bioluminescence. Typically, luciferin, the luciferase substrate, is injected into mice before they are anaesthetized for imaging. To avoid the effects of handling and stress from injection on expression of the transgene, oral luciferin delivery methods were tested as an alternative to current methods. For unobscured imaging, a transgenic mouse line containing luc controlled by the enhancer and promoter for the major immediate-early gene of human cytomegalovirus (CMV) was crossed with a hairless albino mouse stock (HRS/J), resulting in the Hr-CMV line. Mice given food and water ad libitum readily drank 1-5 mM luciferin in water or apple juice and could be imaged repeatedly on subsequent days without any apparent adverse effects. Oral and injected luciferin produced similar patterns of luminescence in the body areas examined: abdomen, tail vertebrae, gonads, hind leg, foreleg and others, although the tail showed a slightly brighter relative luminescence after oral luciferin. These results show that luciferin is not appreciably degraded in the digestive tract and can be easily administered orally to avoid injection and any concomitant effects on behavior that could alter gene expression.


Subject(s)
Firefly Luciferin/administration & dosage , Gene Expression , Water Supply , Administration, Oral , Animals , Female , Luminescence , Male , Mice , Mice, Transgenic
SELECTION OF CITATIONS
SEARCH DETAIL
...